Per-6-substituted [beta]-cyclodextrin libraries inhibit formation of [beta]-amyloid-peptide (A[beta])-derived, soluble oligomers

Alzheimer's disease is the most common cause of dementia in older individuals with compelling evidence favoring neuron dysfunction and death triggered by assembled forms of Aβ^sub 1-42^. While large neurotoxic amyloid fibrils have been known for years, recent studies show that soluble protofibr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of molecular neuroscience 2002-08, Vol.19 (1-2), p.51
Hauptverfasser: Yu, Jiaxin, Bakhos, Lara, Chang, Lei, Holterman, Mark J, Klein, William L, Venton, Duane L
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Alzheimer's disease is the most common cause of dementia in older individuals with compelling evidence favoring neuron dysfunction and death triggered by assembled forms of Aβ^sub 1-42^. While large neurotoxic amyloid fibrils have been known for years, recent studies show that soluble protofibril and Aβ^sub 1-42^-derived diffusible ligands (ADDLs) may also be involved in neurotoxicity. In the present work, dot-blot immunoassays discriminating ADDLs from monomers were used to screen libraries of per-substituted β-cyclodextrin (β-CD) derivatives for inhibition of ADDLs formation. Libraries were prepared from per-6-iodo-β-CD by treatment with various amine nucleophiles. The most active library tested (containing >2000 derivatives) was derived from imidazole, N, N-dimethylethylenediamine and furfurylamine, which at 10 µM total library, inhibited ADDLs formation (10 nM Aβ^sub 1-42^) over a period of 4 hours. The latter was confirmed by a western blot assay showing decreased amounts of the initially formed Aβ^sub 1-42^ tetramer. These preliminary experiments suggest that derivatized forms of β-CD can interfere with the oligomerization process of Aβ^sub 1-42^.[PUBLICATION ABSTRACT]
ISSN:0895-8696
1559-1166
DOI:10.1007/s12031-002-0010-x